These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20886222)

  • 21. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
    Gittings LM; Foti SC; Benson BC; Gami-Patel P; Isaacs AM; Lashley T
    Acta Neuropathol Commun; 2019 Feb; 7(1):18. PubMed ID: 30755280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
    Armstrong RA; Cairns NJ
    Histol Histopathol; 2011 Feb; 26(2):185-90. PubMed ID: 21154232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.
    Cairns NJ; Uryu K; Bigio EH; Mackenzie IR; Gearing M; Duyckaerts C; Yokoo H; Nakazato Y; Jaros E; Perry RH; Arnold SE; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2004 Sep; 108(3):213-23. PubMed ID: 15170578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topography of hemispheric white matter pathology in ten cases of neuronal intermediate filament inclusion disease.
    Armstrong RA
    Clin Neuropathol; 2018; 37(5):239-244. PubMed ID: 29956645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laminar distribution of the pathological changes in sporadic frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy: a quantitative study using polynomial curve fitting.
    Armstrong RA; Hamilton RL; Mackenzie IR; Hedreen J; Cairns NJ
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):335-47. PubMed ID: 22804696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical degeneration in frontotemporal lobar degeneration with TDP-43 proteinopathy caused by progranulin gene mutation.
    Armstrong RA
    Int J Neurosci; 2014 Dec; 124(12):894-903. PubMed ID: 24494724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial correlations between the neuronal inclusions, swollen achromatic neurons, and glial cells in neuronal intermediate filament inclusion disease (NIFID).
    Cairns NJ; Armstrong RA
    J Neural Transm (Vienna); 2005 Apr; 112(4):473-80. PubMed ID: 15375676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions.
    Matsuoka T; Fujii N; Kondo A; Iwaki A; Hokonohara T; Honda H; Sasaki K; Suzuki SO; Iwaki T
    Neuropathology; 2011 Feb; 31(1):71-6. PubMed ID: 20573033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basophilic inclusions and neuronal intermediate filament inclusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Ito H
    Neuropathology; 2014 Dec; 34(6):589-95. PubMed ID: 24673472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
    Mori F; Tanji K; Kon T; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Yoshida M; Wakabayashi K
    Neuropathol Appl Neurobiol; 2012 Jun; 38(4):322-8. PubMed ID: 21883376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.
    Snowden JS; Hu Q; Rollinson S; Halliwell N; Robinson A; Davidson YS; Momeni P; Baborie A; Griffiths TD; Jaros E; Perry RH; Richardson A; Pickering-Brown SM; Neary D; Mann DM
    Acta Neuropathol; 2011 Jul; 122(1):99-110. PubMed ID: 21424531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transportin1: a marker of FTLD-FUS.
    Brelstaff J; Lashley T; Holton JL; Lees AJ; Rossor MN; Bandopadhyay R; Revesz T
    Acta Neuropathol; 2011 Nov; 122(5):591-600. PubMed ID: 21847626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.
    Mackenzie IR; Ansorge O; Strong M; Bilbao J; Zinman L; Ang LC; Baker M; Stewart H; Eisen A; Rademakers R; Neumann M
    Acta Neuropathol; 2011 Jul; 122(1):87-98. PubMed ID: 21604077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA).
    Armstrong RA; Kerty E; Skullerud K; Cairns NJ
    J Neural Transm (Vienna); 2006 Sep; 113(9):1207-15. PubMed ID: 16362634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study.
    Yokota O; Tsuchiya K; Terada S; Ishizu H; Uchikado H; Ikeda M; Oyanagi K; Nakano I; Murayama S; Kuroda S; Akiyama H
    Acta Neuropathol; 2008 May; 115(5):561-75. PubMed ID: 18080129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
    Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
    Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease.
    Mosaheb S; Thorpe JR; Hashemzadeh-Bonehi L; Bigio EH; Gearing M; Cairns NJ
    Acta Neuropathol; 2005 Oct; 110(4):360-8. PubMed ID: 16025283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study.
    Armstrong RA; Cairns NJ
    J Neural Transm (Vienna); 2007; 114(4):451-6. PubMed ID: 17109074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.
    Troakes C; Hortobágyi T; Vance C; Al-Sarraj S; Rogelj B; Shaw CE
    Neuropathol Appl Neurobiol; 2013 Aug; 39(5):553-61. PubMed ID: 22934812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.